Completed NCT02543359
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand what helps a therapy or guided support program stay useful, realistic, and easier to follow over time.
In United States Mental health Behavioral Over 1 Year
Countries United States
Sponsor West Virginia University
Condition Mental health Completed NCT07140926
This study is completed in the United States. It focuses on Addiction.
Remote / online Addiction Behavioral Over 18 Years
Countries United States
Sponsor Bright Therapeutics
Condition Addiction Completed NCT01940159
This study is completed in the United States. It is testing SEP-363856 for schizophrenia.
In United States Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 50 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT07093736
This study is completed in the United States. It focuses on anxiety.
In United States Anxiety Device i A study involving a tool, app, wearable, test, or medical device. Over 18 Years
Countries United States
Sponsor Fisher Wallace Laboratories
Condition Anxiety Active Not Recruiting NCT06008574
This summary needs review. Please check the official study record and contact the research team for details.
In United States Anxiety Behavioral Over 18 Years
Countries United States
Sponsor Memorial Sloan Kettering Cancer Center
Condition Anxiety Completed NCT00634348
This study is completed in the United States. It is testing ziprasidone and Aripiprazole for schizophrenia.
In United States Schizophrenia Drug From 18 Years to 70 Years
Countries United States
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Completed NCT01143077
This study is completed in the United States. It focuses on schizophrenia.
In United States Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Completed NCT01299454
This summary needs review. Please check the official study record and contact the research team for details.
In United States Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04524403
This study is completed in the United States. It focuses on schizophrenia.
In United States Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Schizophrenia Completed NCT02947308
This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
In United States Suicidality Other From 12 Years to 16 Years
Countries United States
Sponsor University of Minnesota
Condition Suicidality Completed NCT00844857
This summary needs review. Please check the official study record and contact the research team for details.
In United States Bipolarity, Depression Drug From 10 Years to 17 Years
Countries United States, Russia
Sponsor Eli Lilly and Company
Condition Bipolarity, Depression Completed NCT00195780
This summary needs review. Please check the official study record and contact the research team for details.
In United States Bipolarity Drug From 10 Years to 17 Years
Countries United States
Sponsor Abbott
Condition Bipolarity